Nailya R. Makhmudova

Nailya R. Makhmudova

Auto-generated profile, based on publicly available information

Nailya R. Makhmudova

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
ILIrina Leneva
Irina Leneva
IFIrina Falynskova
Irina Falynskova
NMNailya R. Makhmudova
Nailya R. Makhmudova
APArtem Poromov
Artem Poromov
SYSvetlana B. Yatsyshina
Svetlana B. Yatsyshina
VMViktor V. Maleev
Viktor V. Maleev

1 August 2005 in Virus Genes
Verified
Journal Article
Closed access
PDF file
ABAndrey Bogoyavlenskiy
Andrey Bogoyavlenskiy
VBVladimir Berezin
Vladimir Berezin
APAlexey Prilipov
Alexey Prilipov
EUEugeniy Usachev
Eugeniy Usachev
OLOlga Lyapina
Olga Lyapina
DKDaniel King
Daniel King

1 April 2008 in Journal of Parasitology
Verified
Journal Article
Closed access
VBVladimir Berezin
Vladimir Berezin
ABA. P. Bogoyavlenskiy
A. P. Bogoyavlenskiy
VTV. P. Tolmacheva
V. P. Tolmacheva
NMN. R. Makhmudova
N. R. Makhmudova
SKS. S. Khudyakova
S. S. Khudyakova
RFR. H. Fetterer
R. H. Fetterer
Immunostimulating complexes (ISCOMs) are unique, multimolecular structures formed by encapsulating antigens, lipids, and triterpene saponins of plant origin, and are an effective delivery system for various kinds of antigens. The uses of ISCOMs formulated with saponins from plants collected in Kazakhstan, with antigens from the poultry coccidian parasite Eimeria tenella, were evaluated for their potential use in developing a vaccine for control of avian coccidiosis. Saponins isolated from the plants Aesculus hippocastanum and Glycyrrhiza glabra were partially purified by HPLC. The saponin fractions obtained from HPLC were evaluated for toxicity in chickens and chicken embryos. The HPLC saponin fractions with the least toxicity, compared to a commercial saponin Quil A, were used to assemble ISCOMs. When chicks were immunized with ISCOMs prepared with saponins from Kazakhstan plants and E. tenella antigens, and then challenged with E. tenella oocysts, significant protection was conveyed compared to immunization with antigen alone. The results of this study indicate that ISCOMs formulated with saponins isolated from plants indigenous to Kazakhstan are an effective antigen delivery system which may be successfully used, with low toxicity, for preparation of highly immunogenic coccidia vaccine.

1 May 2014 in Pharmaceutical Chemistry Journal
Verified
Journal Article
Closed access
PDF file
IFIrina Falynskova
Irina Falynskova
KIK. S. Ionova
K. S. Ionova
ADA. V. Dedova
A. V. Dedova
ILI. A. Leneva
I. A. Leneva
NMN. R. Makhmudova
N. R. Makhmudova
LRL. D. Rasnetsov
L. D. Rasnetsov

1 January 2022 in Russian Bulletin of Otorhinolaryngology
Verified
Journal Article
Closed access
AGAlexander Gurov
Alexander Gurov
TDT.K. Dubovaya
T.K. Dubovaya
AEAleksandr Ermolaev
Aleksandr Ermolaev
ZMZ.V. Murzakhanova
Z.V. Murzakhanova
NMN.R. Makhmudova
N.R. Makhmudova
ADA.KH. Dombalagyan
A.KH. Dombalagyan
Воспалительные заболевания глотки занимают одно из ведущих мест в структуре оториноларингологической патологии. С острыми и хроническими воспалительными процессами в глотке, а также с обострениями последних сталкиваются врачи широкого круга специальностей. Для определения конкретного патогена необходимо лабораторное исследование мазка из ротоглотки, которое требует времени. В связи с этим особый интерес представляют местные лекарственные препараты, обладающие необходимым спектром действия, применение которых возможно в качестве монотерапии или в сочетании с системной терапией. Комбинация тиротрицина (tyrothricin), бензалкония хлорида (benzalkonium chloride) и бензокаина (benzocaine) (доритрицин) обладает высокой эффективностью в лечении бактериальных, вирусных и грибковых поражений глотки, а микроорганизмы стабильно демонстрируют высокую чувствительность к компонентам препарата.

13 December 2019 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
NMN. R. Makhmudova
N. R. Makhmudova
ILIrina Leneva
Irina Leneva
NLN. V. Larionova
N. V. Larionova
APAlexander Poddubikov
Alexander Poddubikov
IFIrina Falynskova
Irina Falynskova
OSOksana Svitich
Oksana Svitich
Introduction. Influenza is a severe viral disease. The most common post-influenza complication is pneumonia. Earlier, we developed an experimental mouse model of viralbacterial pneumonia induced by successive infection with influenza virus and St. aureus, in which lethal synergy between pathogens observed in epidemiological observations was detected.Aim. To study the effect of the administration of intranasal vaccines, followed by infection with St. pneumoniae on the development and completion of the disease.Materials and methods. The animals were immunized intranasal with a strain of attenuated cold-adapted live influenza vaccine A/17/California/2009/38 (H1N1)pdm09 (LAIV) and a recombinant vaccine based on virus-like particles HA(Puerto Rico/8/34)- Gag (VLPs). Control groups of animals were infected with virulent strains of influenza virus A/ California/04/2009 (H1N1)pdm09 or A/Puerto Rico /8/34 (H1N1). On the fifth day after intranasal immunization with the vaccine preparations and infection with pathogenic strains, animals were subjected to bacterial infection with a strain of St. pneumoniae. The presence of synergism of vaccine or viral agent with bacterial infection was assessed by survival and weight loss of animals, virus titer and density of bacteria in nasopharyngeal washes and lungs.Results. It was shown that immunization with vaccine preparations did not lead to increased sensitivity of mice to bacterial infection. Elimination of bacteria from the lungs and nasopharynx in groups immunized with vaccine preparations corresponded to the dynamics in the group of animals immunized by PBS.Discussion. The results obtained indicate the safety of intranasal immunization with LAIV A/17/California/2009/38 (H1N1)pdm09 and virus-like particles HA (Puerto Rico/8/34)- Gag (VLPs) in terms of enhancing secondary bacterial superinfection caused by St. pneumoniae.Conclusion. The studied vaccines successfully blocked infections in the lower respiratory tract.